Deutsche Bank
MDNA

Deutsche Bank’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

Deutsche Bank’s Portfolio MDNA Stock Details MDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-22,900
Closed -$64K – 4452
2021
Q3 		$64K Buy
22,900
+14,700
+179% +$36.4K ﹤0.01% 4051
2021
Q2 		$25K Buy
8,200
+800
+11% +$2.96K ﹤0.01% 4403
2021
Q1 		$30K Sell
7,400
-36,200
-83% -$147K ﹤0.01% 4339
2020
Q4 		$204K Buy
+43,600
New +$176K ﹤0.01% 3458

Other funds holding MDNA

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return

Deutsche Bank's MDNA Position: Q4 2021 in Review

Deutsche Bank sold out of Medicenna Therapeutics Corp. Common Shares (MDNA) in Q4 2021, closing a stake of 22,900 shares — an estimated $64K sold.

Deutsche Bank first reported a position in MDNA in Q4 2020 and held it in 4 quarters. The position peaked at $204K in Q4 2020. 23 funds tracked by Wall St. Rank hold MDNA as of Q4 2021.

  • Deutsche Bank reported no remaining Medicenna Therapeutics Corp. Common Shares position as of Q4 2021 after selling out during the quarter.
  • Deutsche Bank sold 22,900 Medicenna Therapeutics Corp. Common Shares shares in Q4 2021, an estimated $64K.
  • Deutsche Bank first reported a position in Medicenna Therapeutics Corp. Common Shares in Q4 2020 and held it in 4 quarters.
  • Deutsche Bank's Medicenna Therapeutics Corp. Common Shares position peaked at $204K in Q4 2020.
  • 23 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q4 2021.

Based on Deutsche Bank's 13F filing for Q4 2021, filed 11 Feb 2022.